Innovation

Antineoplastic Agents 571. Total Synthesis of Bacillistatins 1 and 2

Arizona State University (AzTE)
posted on 10/08/2009

Invention Description
The cyclodepsipeptides, bacillistatins 1 and 2, possess potent anti-microbial and anti-neoplastic actions. The need for novel antibotics, given the problems with resistance to conventional drugs, is obvious. Anti-microbial drug resistance is the largest human health care problem facing populations worldwide today.
Researchers at Arizona State University have discovered and developed a synthesis method for two novel cyclodepspeptide compounds. bacillistatin 1 & 2, depicted in the attached file, display antibiotic properties against Streptococcus pneumoniae and S. pyogenes in addition to impressive inhibitory effects against a human cancer cell-line panel.
Benefits and

Suggested Uses

  • Anti-cancer agent
  • Antibacterial agent against antibiotic resistant strains

Advantages

  • Synthesis – a method for synthesizing bacillistatin 1 & 2 has been developed and pharmaceutical salts are easily recovered at respectable yields.

Innovation Details
 

File Number: M9-054L 


IP Protection


License Online

This innovation currently is not available for online licensing. Please contact the case manager at Arizona State University (AzTE) for more information.

Request more info via email request more info
People

No people are currently associated with this innovation.


Download Technology Brief (PDF)


Followed By

Follow this innovation



No one is following this innovation.

Organization
Profile
Related Tags

Find more innovations


February 11, 2009

4,461 members 13,003 innovations 112 organizations

Browse

Patrick Jones, Ph.D. Director, Technology Transfer - University of Arizona

"The iBridge Network nicely embodies the ideals of a well-designed, non-profit mechanism for aggregating, searching, and disseminating innovations from multiple research institutions."  read more...